Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2–NF-κB and JNK–AP-1 signaling pathways
- 8 December 2015
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 73 (8) , 1685-1698
Abstract
Endothelial dysfunction involves deregulation of the key extracellular matrix (ECM) enzyme lysyl oxidase (LOX) and the vasoconstrictor protein, endothelin-1 (ET-1), whose gene expression can be modulated by the transcriptional activators nuclear factor kappa B (NF-κB) and activator protein-1 (AP-1). Advanced glycation end products (AGEs) present an aggravating factor of endothelial dysfunction which upon engagement to their receptor RAGE induce upregulation of mitogen-activated protein kinases (MAPKs), leading to NF-κB and AP-1 potentiation. We hypothesized that AGEs could induce NF-κΒ- and AP-1-dependent regulation of LOX and ET-1 expression via the AGE/RAGE/MAPK signaling axis. Western blot, real-time qRT-PCR, FACS analysis and electrophoretic mobility-shift assays were employed in human aortic endothelial cells (HAECs) following treatment with AGE-bovine serum albumin (AGE-BSA) to investigate the signaling pathway towards this hypothesis. Furthermore, immunohistochemical analysis of AGEs, RAGE, LOX and ET-1 expression was conducted in aortic endothelium of a rat experimental model exposed to high- or low-AGE content diet. HAECs exposed to AGE-BSA for various time points exhibited upregulation of LOX and ET-1 mRNA levels in a dose- and time-dependent manner. Exposure of HAECs to AGE-BSA also showed specific elevation of phospho(p)-ERK1/2 and p-JNK levels in a dose- and time-dependent fashion. AGE administration significantly increased NF-κΒ- and AP-1-binding activity to both LOX and ET-1 cognate promoter regions. Moreover, LOX and ET-1 overexpression in rat aortic endothelium upon high-AGE content diet confirmed the functional interrelation of these molecules. Our findings demonstrate that AGEs trigger NF-κΒ- and AP-1-mediated upregulation of LOX and ET-1 via the AGE/RAGE/MAPK signaling cascade in human endothelial cells, thus contributing to distorted endothelial homeostasis by impairing endothelial barrier function, altering ECM biomechanical properties and cell proliferation.Keywords
This publication has 67 references indexed in Scilit:
- Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound HealingInternational Journal of Vascular Medicine, 2012
- Aging and vascular endothelial function in humansClinical Science, 2011
- Endothelin‐1 gene regulationThe FASEB Journal, 2010
- High Glucose Increases Lysyl Oxidase Expression and Activity in Retinal Endothelial Cells: Mechanism for Compromised Extracellular Matrix Barrier FunctionDiabetes, 2010
- Increased Endothelial Exocytosis and Generation of Endothelin-1 Contributes to Constriction of Aged ArteriesCirculation Research, 2010
- Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implicationsReviews in Endocrine and Metabolic Disorders, 2010
- Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– miceJournal of Clinical Investigation, 2008
- Interleukin 1 increases the production of endothelin-1 by cultured endothelial cellsBiochemical and Biophysical Research Communications, 1990